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Abstract: This review aimed to synthesize evidence regarding interventions based on heart rate
variability (HRV)-guided training for VO2max improvements in endurance athletes and address the
issues that impact this performance enhancement. The Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE, EMBASE, CINAHL Complete, the Web of Science Core Collection, Global
Health, Current Contents Connect, and the SciELO citation index were searched. Inclusion criteria
were: randomized controlled trials; studies with trained athletes enrolled in any regular endurance
training; studies that recruited men, women, and both sexes combined; studies on endurance training
controlled by HRV; studies that measured performance with VO2max. A random-effects meta-analysis
calculating the effect size (ES) was used. Moderator analyses (according to the athlete’s level and
gender) and metaregression (according to the number of participants in each group) were undertaken
to examine differences in ES. HRV-guided training and control training enhanced the athletes’ VO2max
(p < 0.0001), but the ES for the HRV-guided training group was significantly higher (p < 0.0001;
ESHRVG-CG = 0.187). The amateur level and female subgroup reported better and significant results
(p < 0.0001) for VO2max. HRV-guided training had a small (ES = 0.402) but positive effect on endurance
athlete performance (VO2max), conditioned by the athlete’s level and sex.
Keywords: performance; heart rate variability; high-level athletes; maximal oxygen uptake
1. Introduction
1.1. Description of the Condition
The key components in any training program are the volume (i.e., how much), intensity
(i.e., how hard), and frequency (i.e., how often) of the exercise sessions, and the combination of
these ‘training impulses’ determines the magnitude of adaptive responses that improve the physical
condition of an athlete or increase fatigue [1]. Combining these key elements to optimize training in
athletes for better performance represents a relevant area of research within exercise physiology and
sports medicine [2]. It is recognized that a standard training program applied to a group of athletes
can induce diverse responses in terms of performance and physiological adaptations [3,4]. Therefore,
individualization is recognized as a training principle [1] as well as the need to adjust training stimuli
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to the psychophysical load capacity and individual tolerance of each athlete, if individual responses
to training and recovery loads are intended for optimal performance [5]. The maximal oxygen
uptake (VO2max) is considered one of the main indicators for measuring an athlete’s performance
and cardiovascular adaptation to training loads [6]. The VO2max is defined as the largest volume of
oxygen that the body can capture, use, and transport during intense exercise [7] and is a determining
factor of endurance performance [7,8]. As Vesterinen et al. [4,9] state, although some athletes show
great endurance performance improvements after standardized group training (even up to 40% in
VO2max), other athletes show no changes or benefits, and sometimes even show a decrease in endurance
performance. In recent years, research has looked at whether heart rate variability (HRV)-guided
training has positive effects on athletic performance, given that this type of training allows daily
adjustment of the training and recovery stimuli, individually based on HRV records [4,5,10].
1.2. Description of the Intervention
HRV is an indicator that enables the noninvasive analysis of autonomic nervous system activity
in both its sympathetic and parasympathetic branches [11]. This is relevant if we consider that an
important component of the interindividual variability in physiological responses to training is related
to the balance between the parasympathetic (PNS) and sympathetic (SNS) activity of the autonomic
nervous system (ANS) [12]. According to Huang et al. [13], HRV is considered the variation in the time
interval between two consecutive heartbeats and obtained by calculating the time interval between
two consecutive R waves (i.e., RR interval fluctuation) in the electrocardiogram (ECG). Since the
elapsed time between beats is not constant, high vagally related HRV values are associated with
efficient ANS, promoting behavioral adaptation and cognitive flexibility during stress [14], while low
HRV is indicative of an inefficient ANS, resulting in maladaptive responses to stress and perceived
threats [13]. HRV analysis is considered a useful method for measuring the heart’s ability to adapt
to endogenous and exogenous loads [15]; therefore, it can be used for the individual assessment of
responses to training loads and recovery adaptation [4,16]. High HRV measurements indicate more
parasympathetic than sympathetic activation, which is indicative of better recovery and preparedness
for facing high-intensity training sessions [17]. HRV-guided training starts with a preparation period
of about four weeks, which serves as a standardized data collection phase to obtain the baseline HRV
values (e.g., LnrMSSD; the natural logarithm of the square root of the mean value of the sum of the
squares of the differences between the adjacent RR intervals) and their normal range (upper and lower
limits) for each athlete [9,18]. Once the normal range of HRV measurements has been established,
the training prescribed (moderate- or high-intensity session) is based on this calculation, which is
normally updated weekly [19]. Traditionally, the vagally related HRV index has been measured with
ECG [20], and quantified by means of rMSSD [17]. Currently, the development and validation of new
applications (i.e., smartphone applications: Kubios-HRV, Elite-HRV, Mobile Lab, or HRV4Training)
facilitate daily HRV measurements and their quantification and, thus, the individual adaptation of
training loads and recovery.
1.3. How the Intervention Might Work
Bellenger et al. [21], in a recent systematic review with meta-analysis, highlighted the need
to use monitoring systems that accurately reflect the athletes’ adaptations to the training stimulus.
Although there have been numerous research studies using the HRV measure to check wellness
and training adaptation in athletes [22,23], these have not focused on performance improvement
based on HRV-guided training but have followed training interventions based on a traditional and
nonindividualized methodology.
In contrast, evidence exists supporting the use of HRV-guided training for improved performance
in endurance athletes. With this type of training monitoring, some studies have found significant
VO2max improvements in athletes who have developed individualized endurance training programs
based on daily HRV values. These studies alternated moderate-intensity sessions with high-intensity
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sessions [4,10] or even rest sessions, vigorous-intensity training, and moderate-intensity exercise [5].
However, Javaloyes et al. [18], in a program with similar characteristics developed with professional
cyclists, found no significant improvements in VO2max. Likewise, significant improvements have been
found among athletes following HRV-guided training in other variables; for example, for lactate in
maximal test [10], speed in maximal test [4], time in maximal test [4,10], or muscle strength [24]. At the
level of perceived recovery, significant improvements have also been found in variables such as general
stress, emotional stress, lack of energy, and even overall mood disturbance [25]. HRV-guided training
may, therefore, function as an alternative method for improving performance in resistance athletes.
1.4. Why Is This Review Important?
In the search to improve athletic performance, different training methods have been tried and
studied, such as intensified training [2] or submaximal tests [26]. However, it has also been recognized
that the same training program followed by a group of athletes can provoke a wide range of reactions
in terms of performance and physiological adaptations [3]. Overuse injuries occur due to repetitive
submaximal loading of the musculoskeletal system when there is inadequate rest to allow for structural
adaptation to take place [27]. In recent years, HRV-guided training has shown itself to be a promising
method for improving different performance variables (e.g., VO2max) compared to predefined training
(traditional training) through the monitoring and individualization of endurance athletes’ training [4,28].
HRV-guided training has been investigated in randomized trials on samples from different endurance
sports, such as skiers [28], runners [4,25], and cyclists [18]), as well as athletes of different ages and
levels: elite [18,28] and recreational endurance athletes [5,24,25]. Therefore, it is important to carry
out a systematic review and meta-analysis of the different experimental studies conducted so far
on endurance athletes in order to assess whether HRV-guided training is an effective method for
performance improvement.
2. Objectives
As mentioned above, this review aimed to analyze the effect of HRV-guided training on VO2max
in endurance athletes.
We asked the following research questions regarding HRV-guided training in endurance athletes:
Research Question 1: Does HRV-based training have an effect on VO2max?
Research Question 2: Is the effect of this type of training superior to that of traditional training?
Research Question 3: Is the level of the athletes decisive in obtaining an effect on the VO2max?
Research Question 4: Does the effect of HRV-guided training determine VO2max scores according to
the gender of the athlete?
3. Methods
The methods detailed below are reported in accordance with the Campbell Collaboration policies
and guidelines for systematic reviews [29].
3.1. Criteria for Considering Studies for This Review (Eligibility Criteria)
3.1.1. Types of Studies
We included randomized controlled trials (RCTs) and the first period of cross-over RCTs and
experimental studies using a random method for the treatment assignment in order to reduce the risk
of allocation bias. We restricted study eligibility by language. We did not restrict study eligibility by
publication status.
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3.1.2. Types of Participants
We included studies with trained athletes enrolled in any form of regular endurance training
(e.g., runners, triathletes, skiers, and cyclists). We included studies that recruited both men and women,
or men and women separately.
3.1.3. Types of Interventions
We included studies on endurance training controlled by heart rate variability to improve the
athletes’ performance. We considered designs comprising any dose, frequency, and duration. We also
considered studies with the following types of comparisons:
• Endurance training controlled by HRV versus no specific training intervention (e.g., habitual
physical activity).
• Endurance training controlled by HRV versus another training intervention (e.g., traditional
endurance training or another type of traditional training).
• Endurance training controlled by HRV versus another training intervention (i) versus a further
training intervention (ii).
• Endurance training controlled by HRV (i) versus endurance training controlled by HRV (ii) versus
another training intervention versus no specific training intervention.
3.1.4. Types of Outcome Measures
• Primary
◦ Maximal oxygen consumption (VO2max)
3.2. Search Methods to Identify the Studies
3.2.1. Electronic Searches
The register contains studies identified from the Cochrane Central Register of Controlled
Trials (CENTRAL), MEDLINE, EMBASE, CINAHL Complete, the Web of Science Core Collection,
Global Health, Current Contents Connect, and the SciELO citation index.
The search is up to date as of 15 June 2020. The language was restricted, considering only English
or Spanish. The terms used to search the databases were: (amateur OR elite OR train*) AND (HRV-guided
OR “heart-rate variability guided”).
3.2.2. Searching Other Resources
We checked the reference lists of all the included studies and systematic reviews for additional
references. We contacted experts in the field and the authors of the included studies to identify
additional unpublished studies. We also checked the results of completed trials registered on the US
National Institutes of Health Ongoing Trials Register, ClinicalTrials.gov, the World Health Organization
International Clinical Trials Registry Platform (WHO ICTRP), and proceedings of conferences for
relevant research.
3.3. Data Collection and Analysis
We conducted the following data collection and analysis in accordance with the recommendations
in the Cochrane Handbook for Systematic Reviews of Interventions [30].
3.3.1. Selection of Studies
Two review authors independently screened the titles and abstracts of all the retrieved references
in Microsoft Excel 2018 (Microsoft, New York, NY, USA) for Windows. The full-text study reports were
retrieved for all the citations that at least one review author considered potentially relevant. Two review
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authors independently screened the full-text articles and identified studies for inclusion; they also
identified and recorded the reasons for excluding studies in the excluded studies characteristics. Any
disagreements were resolved through discussion. The selection process is detailed in a PRISMA flow
diagram [31].
3.3.2. Data Extraction and Management
We used a standardized piloted data collection form in Microsoft Excel 2018 for Windows
and extracted the following study characteristics and outcome data: (i) Methods: study design;
(ii) Participants: randomized number, study participants’ mean age or age range, study location
and setting, recruitment methods, inclusion and exclusion criteria, and type of endurance sport;
(iii) Interventions: a description of the training intervention characteristics, the dose and duration of
the training intervention, a description of the comparison intervention characteristics, the length of
follow-up, the number of withdrawals, and the reasons for withdrawal; (iv) Outcomes: a description
of the primary and secondary outcomes in the review that were reported in the trial and a listing of
other outcomes collected in the trial; (v) Notes: the trial funding and notable conflicts of interest of
the trial authors; (vi) a ‘risk of bias’ assessment. Two review authors independently extracted the
outcome data from the included studies into Microsoft Excel 2018 spreadsheets and compared the
data to identify any discrepancies in the data entries. Any disagreements were resolved by consensus.
In the Characteristics of Included Studies section, we noted down if a trial did not report outcome
data in a usable way. We then transferred all the outcome data into the Comprehensive Meta-Analysis
software version 2.2.064 (Biostat, Englewood, NJ, USA) [32].
3.3.3. Risk-of-Bias Assessment in the Included Studies
Two review authors (M.C.P., A.G.G.) independently assessed the risk of bias for each included trial
using the Cochrane risk-of-bias tool [30]. Any disagreements were resolved by discussion. The risk of
biases were assessed for the following domains: random sequence generation (selection bias), allocation
concealment (selection bias), blinding of participants and personnel (performance bias), blinding
of outcome assessment for each outcome (detection bias), incomplete outcome data (attrition bias),
selective outcome reporting (reporting bias), and other biases (such as the validity of outcome measure
and baseline comparability). Each potential source of bias was assessed as either high, low, or unclear,
and a quotation from the study report was provided together with a justification for the judgment in
the ‘risk of bias’ tables. The judgments across the different studies were summarized for each of the
domains listed.
3.3.4. Treatment Effect Measures
The outcome data for each study were uploaded into the data tables of the Comprehensive
Meta-Analysis software to calculate the treatment effects. We used the mean difference
(MD) for continuous outcomes reported on the same scal, and the standardized mean
difference (SMD) for continuous outcomes measured on different scales in different trials
(SMD = MHRV guided training − Mcontrol group/Standard deviation) [33]. Uncertainty was expressed
with 95% confidence intervals (CIs) for all the effect estimates.
3.3.5. Assessment of Heterogeneity and Reporting Bias
Heterogeneity was assessed qualitatively between studies in three ways: a visual examination of
the forest plots, the Chi2 test (p ≤ 0.10) for heterogeneity, and the I2 statistic. The implications of the
observed I2 statistic value were considered as follows: 0% to 40%—might not be important; 30% to
60%—may represent moderate heterogeneity; 50% to 90%—may represent substantial heterogeneity;
75% to 100%—considerable heterogeneity [30]. Publication bias was assessed by examining the
asymmetry of a funnel plot using Egger’s test. If studies were distributed symmetrically around the
mean effect size (ES), there was an absence of publication bias [33]. Subgroup analysis was carried out
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using the outcome for athlete level (elite vs. amateur) and sex (men, women, and both sexes combined).
Metaregression was used to assess the relationship between the studies and the variable sample size.
3.3.6. Sensitivity Analysis
A sensitivity analysis was carried out to check whether the results varied according to the
endpoint data.
4. Results
4.1. Description of the Studies
4.1.1. Search Results
The search produced a total of 36 studies, with 222 additional records identified through other
sources. The removal of duplicates resulted in eleven studies, which were screened by the two authors
based on the title and abstract. Three studies were excluded. Eight full-text articles were assessed for
eligibility. Two more studies were excluded, and six studies were included either in the qualitative
analysis or in the quantitative metasynthesis. The PRISMA flow chart illustrates the search and
selection process (Figure 1).
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4.1.2. Included Studies
Six studies carrying out HRV-guided training with elite or amateur athletes were included in this
review [4,5,10,18,19,28], which were identified by the first author and publication date: Javaloyes_2019,
Kiviniemi_2007, Kiviniemi_2010, Nuuttila_2017, Schmitt_2018, and Vesterinen_2016.
• Study location
Schmitt_2018 conducted their study at the French National Ski-Nordic Center, while the locations
for the other five studies were not specified.
• Study design
Every study included in this review was a randomized controlled trial.
• Participants
A total of 195 participants (134 men and 61 women) were included in these studies. Kiviniemi_2007,
Javaloyes_2019, and Nuuttila_2017 considered only male samples of 30, 17, and 32 participants,
respectively. In the rest of the studies, the samples were composed of men and women: Kiviniemi_2010
included 24 men and 36 women, Schmitt_2018 incorporated 19 men and 5 women, and Vesterinen_2016
assessed 20 men and 20 women. In the studies by Javaloyes_2019 and Schmitt_2018, the samples were
composed of professional athletes (cyclists and Nordic skiers, respectively) while in the other four
studies, the samples were of a nonprofessional level.
• Interventions
According to the types of comparisons contemplated in the present systematic review
((a) endurance training controlled by HRV versus no specific training intervention; (b) endurance
training controlled by HRV versus other training intervention; (c) endurance training controlled by
HRV (i) versus another training intervention (ii) versus another training intervention; (d) endurance
training controlled by HRV (i) versus endurance training controlled by HRV (ii) versus other
training intervention versus no specific training intervention. Kiviniemi_2007, Javaloyes_2019,
Nuuttila_2017, and Vesterinen_2016 were classified in Comparison B, Schmitt_2018 in Comparison C,
and Kiviniemi_2010 in Comparison D.
The interventions in the included studies focused on running (Kiviniemi_2007, Kiviniemi_2010,
Nuuttila_2017, and Vesterinen_2016), skiing (Schmitt_2018), and cycling (Javaloyes_2019). They were
from 6 to 15 weeks long. In most of the studies, three (Nuuttila_2017) or four (Javaloyes_2019,
Schmitt_2018, and Vesterinen_2016) low-intensity preparation weeks were followed either by the
experimental or control groups (standard training) before the intervention. An eight-week intervention
was carried out in Javaloyes_2019, Kiviniemi_2010, Nuuttila_2017, and Vesterinen_2016, whereas
Kiviniemi_2007 considered four weeks of training and Schmitt_2018 15 days. The assessment
weeks were treated separately from the intervention period in Javaloyes_2019, Kiviniemi_2007,
and Schmitt_2018.
In every study, the experimental groups trained at moderate or high intensities according to their
daily HRV scores. The control groups (standard training) followed a predefined training design at
high, moderate, and low intensities (Javaloyes_2019), high and moderate intensities (Kiviniemi_2010
and Nuuttila_2017), high and low intensities (Kiviniemi, 2007) or moderate and low intensities
(Vesterinen_2016). The control group (standard training) design was not explained in Schmitt_2018.
• Outcomes
The primary outcome analyzed in the included studies was VO2max. The secondary outcomes
were: ventilatory thresholds (Javaloyes_2019, Kiviniemi_2007) and power in the cycling test
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(Javaloyes_2019); rMSSD or RR interval (Javaloyes_2019, Kiviniemi_2007, and Schmitt_2018); basal heart
rate (Nuuttila_2017, Kiviniemi_2010, and Schmitt_2018); maximal heart rate in the ergometer test
(Nuuttila_2017); speed in the treadmill test (Kiviniemi_2007, Nuuttila_2017, and Vesterinen_2016);
maximal speed in the 10 m test (Nuuttila_2017); time and lactate in the 3000 m test (Nuuttila_2017);
maximal load in the ergometer test (Kiviniemi_2007 and Kiviniemi_2010); and oxygen saturation and
VO2 at the second ventilatory threshold (Schmitt_2018).
Further details about participants, interventions, comparators, and outcomes are provided in
Table 1.
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Table 1. Overview of the studies included in the review.
Author, Year Method Participants Intervention Outcomes Results
Risk of Bias
Bias Author’sJudgment Support for the Judgment
Javaloyes_2019 Randomized
controlled trial
Trained male cyclist, mean age of
38.42 years.
N = 17: EG = 9 + CG = 8
Location: not specified.
Recruited from local clubs
Inclusion criteria: at least 2 years
of experience in cycling.
Exclusion criteria: not specified.
15 weeks (4 weeks of baseline period to
capture baseline HRV + 8 weeks of
training + 3 weeks of assessments); 4–7
sessions/week; time depended on the
training intensity.
EG: HRV-G-based training before each
session; training MICT and HIIT
according to HRV.
CG: 4 high-intensity training sessions + 4
high-intensity interval training sessions +
6 moderate-intensity training sessions +
2–5 low-intensity training sessions/week.
No follow-up periods.
No withdrawals




in the graded test, peak power
output in the graded test, rMSSD
with a heart rate monitor + kubios
(LnrMSSD) in a supine position for
90 s, mean power output during a
40 min all-out cycling test.




differences (EG = 24%; CG = 27%).
VT2: significant improvements in
EG (36.11 ± 3.73W). Peak power
output: significant improvements
in EG (17.45 ± 3.91W). LnrMSSD:
significant differences between
intergroups for the percentage of
change (EG = 0.85 ± 3.21%,
CG = –2.02 ± 5.21%). Mean power
40M: significant improvements in










and the outcome is likely to
be influenced by lack of
blinding.
Detection Unclear The study did not addressthis outcome.
Attrition Low No missing outcome data.
Reporting Unclear
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
Other Low The study appears to befree of other sources of bias.
Kiviniemi_2007 Randomizedcontrolled trial
30 healthy recreational male
runners
N = 30: TRA: predefined training
group (n = 10) + HRV:
HRV-guided training (n = 10) +
CG: Control group (n = 10).
Location: Not specified
Recruitment: The candidates were
interviewed with a standardized
scheme to ascertain their medical
history and levels of physical
activity.
Inclusion criteria: healthy men.
Exclusion criteria: subjects who
had done regular physical exercise
training less than twice a week for
the past 3 months, competing
athletes, and subjects with diabetes
mellitus, asthma, or cardiovascular
disorders were excluded.
6 weeks: 1-week baseline resting + pretest
Intervention: 4-week training period (6
days per week) consisting of running
sessions at either a low- or high-intensity
level according to recommendations by
the American College of Sports Medicine:
low-intensity: 40 min of jogging at 65% of
maximal HR; high-intensity exercise
included 5 min warm-up and cool-down
periods at 65% of the maximal HR before
and after 30 min of running at 85% of
maximal HR. The last week for the
post-test.
HRV: exercised at low- or high-intensity or
rested based on their daily HRV
measurements at home. If HRV increased
or did not change, vigorous-intensity
training on that day. If HRV decreased,
moderate-intensity exercise or rest.
TRA: weekly training started with
low-intensity exercise followed by two
sessions of high-intensity exercise on
successive days. This 3-day period was
repeated before a day of rest.
CG: no intervention
No follow-up period.
4 withdrawals: TRA (2); HRV (1); CG (1).
Primary: VO2peak (maximal
treadmill ergometer test: direct
measurement).
Secondary: high-frequency power
of RR interval with software while
standing for 5 min, maximal load
in the ergometer test, maximal
running velocity in the ergometer
test; ventilatory threshold (VT)
from the relation of running
velocity and selected ventilatory
parameters.
VO2peak: significant intragroup
improvements in the HRV group
(pretest = 56 ± 4; post-test = 60 ± 5
mL/kg/min).
High-frequency power of RR
interval: significant intragroup
improvements in TRA
(pretests = 4.7 ± 0.4; post-test = 5.5
± 0.8 ln ms2), and HRV
(pretests = 4.8 ± 0.6; post-test = 5.2
± 0.8 ln ms2). Maximal load:
significant intragroup
improvements in TRA
(pretest = 15.1 ± 1.3 km/h;
post-test = 15.7 ± 1.2 km/h);
significant intergroup differences
between CG (post-test = 14.9 ± 1.5
km/h) and TRA (post-test = 15.7 ±
1.2 km/h), TRA and HRV
(post-test = 16.4 ± 1.0 km/h),
and between CG and HRV. VT:
significant intragroup
improvements in HRV
(pretest = 12.2 ± 0.6 km/h;

















judgment of ‘low risk’ or
‘high risk’.
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
The study did not address
this outcome.
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’
The study appears to be
free of other sources of bias.
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Table 1. Cont.
Author, Year Method Participants Intervention Outcomes Results
Risk of Bias
Bias Author’sJudgment Support for the Judgment
Kiviniemi_2010 Randomized
controlled trial
Healthy men and women. Mean
age of 34.57 years.
N = 60. Men, n = 24; women,
n = 36).
ST: standard training (8 men + 8
women) + HRV-I: HRV-guided
training for men and women (EG:
8 men + 8 women) + HRV-II:
HRV-guided training tailored for





Inclusion criteria: healthy men and
women
Exclusion criteria: smoker, BMI ≥
30 kg/m2; regular physical exercise
training more than twice a week
for the last 3 months, competing
athletes, mellitus, asthma, or
cardiovascular disorders.
8 weeks of aerobic exercise sessions
(40 min), vigorous-intensity level: HR
between 85% of the HRpeak-5 bpm lower
limit; moderate-intensity exercise was 70%
of the HRpeak-5 bpm lower limit.
HRV-I: if HRV increased or did not
change, vigorous-intensity training on
that day. If HRV decreased,
moderate-intensity exercise or rest.
HRV-II: vigorous-intensity exercise only
when HRV had increased.
ST group: two moderate-intensity and
three vigorous-intensity exercises weekly.
CG: no intervention
No follow-up period.
7 withdrawals: ST (1 man + 1 woman) +
HRV-I (7 men + 7 women); CG (7 men + 8
women) + HRV-II (10); 4 because of illness
or injury and 3 because of insufficient
compliance.
Primary: VO2max (maximal bicycle
ergometer test: direct
measurement).
Secondary: HR, RR interval with a
heart rate monitor (SD1) while
standing for 3 min, maximal load
in the ergometer test.
VO2max: significant intragroup
improvements in ST (men
subgroup) (pretest = 50 ± 7;
post-test = 53 ± 7 mL/kg/min), ST
(women subgroup) (pretest = 35 ±
5; post-test = 37 ± 4 mL/kg/min),
HRV-I (men subgroup)
(pretest = 50 ± 6; post-test = 54 ± 6
mL/kg/min), HRV-I (women
subgroup) (pretest = 36 ± 4;
post-test = 39 ± 3 mL/kg/min),
and in HRV-II (women subgroup)
(pretest = 37 ± 5; post-test = 40 ± 5
mL/kg/min).
HR: RR interval: significant
intragroup improvements in HRV-I
(men subgroup) (pretests = 13.7 ±
6.7; post-test = 16.9 ± 8.7 ms).
Maximal load: significant
intragroup improvements in ST
(men subgroup) (pretest = 275 ± 28
W; post-test = 293 ±35 W), ST
(women subgroup) (pretest = 179
± 32 W; post-test = 198 ± 35 W),
HRV-I (men subgroup)
(pretest = 270 ± 29W;
post-test = 300 ± 25 W), HRV-I
(women subgroup) (pretest = 174
± 28 W; post-test = 189 ± 25 W),
and in HRV-II (women subgroup)
(pretest = 177 ± 26 W;
post-test = 194 ± 23 W)
Selection High
Allocation based on the
results of a laboratory test
or a series of tests.
Performance Unclear
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
Detection Unclear The study did not addressthis outcome.
Attrition High High rates of loss tofollow-up.
Reporting Unclear
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.









Exclusion criteria: not specified
11 weeks (3 weeks of control + 8 weeks of
training). EG: 2–5 sessions/week; CG: 6
sessions/week; time depended on the
training intensity.
EG: 4 moderate-intensity endurance
training sessions + 20 high-interval
intensity training sessions. Training MICT
and HIIT according to HRV.
CG: 22 moderate-intensity endurance
training sessions + 20 high-interval
intensity training sessions + 4
high-intensity strength training sessions
No follow-up periods.
9 withdrawals: illness (n = 1), injuries
(n = 2), personal reasons (n = 3), lack of




Secondary: basal heart rate,
maximal heart rate, lactate in the
treadmill test, Vmax in the
treadmill test, Vmax in the 10m
test, time and lactate in the 3000 m
test, rMSSD with a heart rate
monitor + Firstbeat in a supine
position for 3 min.
Other: body weight, height in
countermovement jump, strength
in the concentric dynamic leg press,
nocturnal heart rate variability,
testosterone, and cortisol (blood
samples), % of fat (InBody 720).
VO2max: significant intragroup
changes (EG = 3.1 ± 0.8 mL/kg/min;
CG = 2.2 ± 0.6 mL/kg/min).
Basal HR: significant intragroup
decrease (EG = 4.4 ± 0.6 bpm;
CG = 3.6 ± 0.1 bpm). Vmax in the
treadmill test: significant
intragroup improvements
(EG = 0.9 ± 0.1km/h; CG = 0.5 ± 0.1
km/h). Vmax in 10 m: decreased
significantly in CG from pre to
mead test (0.08 ± 0.04 m/s). Time
in the 3000 m test: significant
intragroup decrease (EG = 35 ± 2 s;
CG = 35 ± 6 s). Lactate in the 3000
m test: significant intragroup
improvements (EG = 12 ± 18.4%)
from mead-to post-test; CG = 16–0
± 23.5%) from pre-to post-test.
rMSSD: significant improvements
in EG (13 ± 3 ms)
Selection High
Allocation based on the
results of a laboratory test
or a series of tests.
Performance Unclear
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
Detection Unclear The study did not addressthis outcome.
Attrition High High rates of loss tofollow-up.
Reporting Unclear
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
Other Low The study appears to befree of other sources of bias.
Int. J. Environ. Res. Public Health 2020, 17, 7999 11 of 21
Table 1. Cont.
Author, Year Method Participants Intervention Outcomes Results
Risk of Bias
Bias Author’sJudgment Support for the Judgment
Schmitt_2018 Randomized
controlled trial
24 elite Nordic skiers (19 men, age
23.3 ± 3.6; 5 women, age 22.8 ± 4.1).
N = 24; H-HRV, HRV-guided
training normobaric hypoxic
group (n = 9) + H, sleeping in
normobaric hypoxia group (n = 9);
N, normoxia group (n = 6).
Location: French National
Ski-Nordic Center.
Recruitment: members of the
cross-country ski and Nordic
combined French.
Inclusion criteria: elite Nordic
skiers.
Exclusion criteria: a history of
altitude-related sickness and
health risks that could compromise
the subject’s safety during training
and/or hypoxic exposure.
Prior to pretest: 3 low-intensity training
weeks (base training) with progressive
training volume + 1-week recovery;
Intervention: pretest + 15 days training
(training load was organized into four
training zones depending on the intensity
and quantified as in Mujika et al. (1996),
adapted to Nordic skiing (the threshold
for training adjustment was chosen as 30%
of the mean of the previous day) +
postest1 + 1 week + postest2. Similar
training content for each group.
H-HRV group: sleeping normobaric in
hypoxia (simulated altitude of 2700 m)
with HRV-guided training; daily hypoxic
dose was similar between H-HRV and H;
Night SpO2 was similar between H-HRV
and H, but lower than in N.
H: traditional training sleeping in hypoxia
(simulated altitude of 2700 m).
N: traditional training sleeping in
normoxia.





Secondary: basal HR, peripheral
oxygen saturation (SpO2), RR
interval with a heart rate monitor
(HF and LF) 5 min in a supine
position and 5 min in standing,
VO2 at the second ventilatory
threshold.
Others: duration of hypoxic





changes in H-HRV (3.8 ± 3.1%).
Basal HR: significant intergroup
differences (H-HRV = 55.38 ± 10.02
vs. H = 55.59 ± 4 bpm;
H-HRV = 55.38 ± 10.02 vs.
N = 47.11 ± 6.21 bpm). SpO2:
significant intergroup differences
(H-HRV = 90.4 ± 1.3 vs. N = 94.2 ±
0.8%). RR interval: no significant
differences between intergroups
(H-HRV = 9561.10 ± 9436.02 ms2;
H = 12,199.41 ± 1293.14 ms2;
N = 7441.2 ± 4954.16 ms2). VO2
second VT: significant intragroup
changes for H-HRV (6.7 ± 6.1%).
Selection High
Allocation based on the
results of a laboratory test
or a series of tests.
Performance Unclear
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
Detection Unclear The study did not addressthis outcome.
Attrition Low No missing outcome data.
Reporting High








(men = 20; women = 20)




Inclusion criteria: 2 years’ regular
endurance running training.
Exclusion criteria: disease or
regular medication for chronic or
long-term diseases.
12 weeks (4 weeks of preparation + 8
weeks of training). The same volume as
before the study for PREP and the same
volume as for PREP for INT.
EXP: training MICT and HIIT according to
HRV.
TRAD: 50% sessions at low-intensity and
50% sessions at moderate/high-intensity.
Week periodization, 3:1.
No follow-up periods.
9 withdrawals: sicknesses (n = 2), injuries




Secondary: Speed in Lactate 1,
speed in Lactate 2, mean speed in
the 3000 m test, time in the 3000 m
test, RR intervals (rMSSD) 4 min in
a supine position.
VO2max: significant intragroup
improvements (EXP = 3.7 ± 4.6%,
TRAD = 5.0 ± 5.2%).
Speed in L1 significant intragroups
improvement in EXP (2.8 ± 3.7%).
Speed in L2 significant intragroups
improvement in EXP (2.6 ± 3.3%)
and TRAD (1.9 ± 2.2%). Time in
the 3000 m test: significant
intragroup improvements in EXP
(–14.3 ± 14.1 s)
Selection High
Allocation based on the
results of a laboratory test
or a series of tests.
Performance Unclear
Insufficient information to
permit judgment of ‘low
risk’ or ‘high risk’.
Detection Unclear The study did not addressthis outcome.
Attrition High High rates of loss tofollow-up.
Reporting High




Other Low The study appears to befree of other sources of bias.
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4.1.3. Excluded Studies
As indicated in Figure 1, five studies were excluded from the qualitative analysis. Three studies
were excluded because the VO2max was not considered as an outcome [24,25,34], and two studies were
excluded because they were not RCTs [35,36].
4.2. Risk of Bias in the Included Studies
The risk of bias in the included studies is summarized in Table 2. This assessment was made
following the Cochrane Collaboration guidelines [30]. In addition, publication bias was assessed
using a funnel plot (Figure 2). The Egger test provided statistical evidence of funnel plot symmetry,
suggesting the absence of a significant publication bias (p = 0.101).
Table 2. Risk of bias in the included studies.
Study
Risk-of-Bias Domains




Javaloyes_2019 Unclear High Unclear Low Unclear Low Unclear
Kiviniemi_2007 Unclear Unclear Unclear Unclear Unclear Low Unclear
Kiviniemi_2010 Unclear Unclear Unclear High Unclear Low Unclear
Nuuttila_2017 High Unclear Unclear High Unclear Low Unclear
Schmitt_2018 High Unclear Unclear Low High Low Unclear
Vesterinen_2016 High Unclear Unclear High High Low Unclear
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• Selection bias
In Javaloyes_2019, Kiviniemi_2007, and Kiviniemi_2010, neither the random component in the
sequence generation nor the allocation concealment were described; therefore, the risk-of-bias selection
was considered unclear. In Nuuttila_2017, Schmitt_2018, and Vesterinen_2016, the risk of bias was
considered high because the randomization sequence was, in the first stage, based on the results of
certain physical condition tests, sport discipline, age, or gender. Furthermore, in the second stage,
the random component or the allocation concealment was not described.
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• Performance and detection bias
The detection bias was considered unclear in all of the included studies because they did not
address this outcome. The performance bias was also unclear in every study but Javaloyes_2019, which
was considered high because only the participants were blinded, thus the blinding was incomplete.
• Attrition bias
In Javaloyes_2019 and Schmitt_2018, the attrition bias was considered low because there were
no missing outcome data. On the other hand, Kiviniemi_2010, Nuuttila_2017, and Vesterinen_2016
presented high rates of follow-up loss for different reasons. These might be relevant in the ES observed.
Moreover, no statistical procedure, such as intention-to-treat, was used to minimize this risk of bias.
Therefore, they were considered as having a high risk of attrition bias. Finally, in Kiviniemi_2007,
the attrition bias was unclear because this outcome was not addressed in the study.
• Reporting bias
The study protocols for the included studies were not available. Accordingly, Javaloyes_2019,
Kiviniemi_2007, Kiviniemi_2010, and Nuuttila_2017 were considered as having an unclear reporting
bias. For their part, Schmitt_2018 and Vesterinen_2016 did not report every outcome and were thus
considered as having a high risk of reporting bias.
• Other biases
The included studies appear to be free from other sources of bias.
4.3. Synthesis of Results
The Kiviniemi_2010 and Schmitt_2017 studies were segmented for quantitative analysis according
to their intervention groups. The comparisons were: Kiviniemi_2007 a, HRV (male subgroup,
HRV-guided training) vs. standard training (ST); Kiviniemi_2010 a, HRV-1 (male subgroup, HRV-guided
training) vs. standard training (ST); Kiviniemi_2010 c, HRV-I (female subgroup, HRV-guided training)
vs. standard training (ST); Kiviniemi_2010 g, HRV-II (female subgroup, HRV-guided training tailored
for women) vs. HRV-I (female subgroup, HRV-guided training); Kiviniemi_2010 f, HRV-II (female
subgroup, HRV-guided training tailored for women) vs. standard training (ST); Schmitt_2017 a HRV
(HRV-guided training) vs. N (traditional training and normoxia sleeping); Schmitt_2017 b HRV
(HRV-guided training) vs. H (traditional training and hypoxia sleeping). Therefore, the total number
of individual studies analyzed were 17 (k = 7 for the experimental group; k = 10 for the control group).
• Primary outcome measures
There were five studies (Kiviniemi_2007, Kiviniemi_2010, Nuuttila_2017, Schmitt_2017 and
Vesterinen_2016) with significant intragroup VO2max improvements in the HRV-guided training group
(n = 95), while no significant changes were found in Javaloyes_2019 (n = 9). On the other hand, in three
studies (Kiviniemi_2010, Nuuttila_2017, and Vesterinen_2016), there were also significant intragroup
VO2max improvements in the control group (n = 47). The overall risk of bias was considered high in
every study but for Javaloyes_2019, which was considered unclear. A random-effects meta-analysis
of the six studies revealed a statistically significant (p < 0.0001) treatment effect for VO2max in the
HRV-guided training intervention (ES = 0.402; 95% CI = 0.273, 0.531). Moreover, the other training
intervention was also statistically beneficial (p < 0.0001) for VO2max improvements in the control
group (ES = 0.215; 95% CI = 0.101, 0.329). However, the ES for the VO2max was significantly higher
(p < 0.0001) in the HRV-guided training group. The heterogeneity observed in the meta-analysis was
significant and high in the overall analysis (p < 0.0001; I2 = 94.24%) and for the experimental (p < 0.0001;
I2 = 9.36%) and the control group (p < 0.0001; I2 = 92.26%) (Figure 3).
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weight determines how much each individual study contributes to the pooled estimate; 95%CI,
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• Moderator analyses
Owing to the high heterogeneity observed in the meta-analysis, the potential moderating effect of
the following was considered to be of interest: (a) the athletes’ level (elite vs. amateur) and (b) the
sex of the participants (‘men vs. women’ vs. ‘men and women’). We had originally planned to take
into account the intervention duration; however, it was not finally included as a subgroup owing to
there being only one study that considered an intervention period of 15 days (Schmitt_2017) while
the others conducted an eight-week intervention. The sample size was used for the metaregression.
Following the moderating variables (Table 3), the athletes’ level (elite vs. amateur) brought about
statistically significant improvements (p < 0.0001) in both subgroups, while there were statistically
significant differences between the subgroups (p < 0.0001) in favor of the nonprofessional subgroup
(elite, ES = 0.17; amateur, ES = 0.36). According to the sex subgroups (‘men vs. women’ vs. ‘men and
women’), there were statistically significant improvements (p < 0.0001) in the three subgroups and
statistically significant differences (p < 0.0001) between the three subgroups in favor of the women
(men, ES = 0.33; women, ES = 0.40; men and women, ES = 0.19). The metaregression findings (Figure 4)
revealed that the sample size of the studies was directly related to the ES magnitude (regression
coefficient = −0.016; standard error = 0.003; lower limit = −0.023; upper Limit = −0.011; Z-value = −5.42;
p ≤ 0.0001).
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Table 3. Subgroup analyses for measuring their impact on VO2max.
Research Studies Variable: VO2max






































(0.06; 0.33) 92.10 0.006
Note: SMD, standard mean difference; CI, confidence interval; VO2max, maximal oxygen uptake; I2 = I-squared.
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5. Discussion
5.1. Summary of Main Results
Six RCT studies evaluating the effects of an HRV-guided training intervention on endurance
athletes were included in this review. The results of the meta-analyses provide some evidence that
either HRV-guided training or traditional training may improve their performance in terms of VO2max
(HRV-G: ES = 0.402, p < 0.0001; CG: ES = 0.215, p < 0.0001). However, more favorable outcomes
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(p < 0.0001) for the experimental groups compared to the control groups were recorded across the
studies. Moderators indicated larger effect sizes for interventions involving amateur endurance athletes
(ES = 0.36, p < 0.0001) and women (ES = 0.40, p < 0.0001). On the other hand, the sample size of the
studies was directly related to the ES magnitude (p < 0.0001).
5.2. Overall Completeness and Applicability of the Evidence
The total sample size of the studies meeting our original inclusion criteria was sufficiently large to
warrant restricting the results to a meta-analysis of the RCTs. Data on the primary outcome (VO2max)
were measured directly using a gas exchange analysis system and a maximal test in each study. This
is the most accurate way to obtain cardiorespiratory data. However, some studies implemented
this test using a treadmill (Kiviniemi_2007, Nuuttila_2017, Schmitt_2017, and Vesterinen_2016) and
others using a cycle ergometer (Javaloyes_2019 and Kiviniemi_2010). In the first case, training was
based on running (Kiviniemi_2007, Nuuttila_2017, and Vesterinen_2016) and skiing (Schmitt_2017),
which implies similar technical execution in the test. In the second case, the Javaloyes_2019 study
was carried out on cyclists, whereas the Kiviniemi_2010 study sample was composed of runners.
Statistical improvements regarding VO2max were found in the Kiviniemi_2007 and Kiviniemi_2010
studies. However, the specificity of the test may be a source of variability and potential imprecision in
the second study results. Following the training specificity principle [37], the body’s physiological
and metabolic responses and training adaptations are specific to the type of exercise and the muscle
groups involved. Thus, the evaluation method should be as similar as possible to the training in order
to obtain the most reliable results. This needs to be taken into account when interpreting the results.
Despite the intervention durations being quite homogeneous in the included studies (eight
weeks for each study apart from Kiviniemi_2007 and Schmitt_2017), the total duration of the training
process, preparation weeks included, endurance sport modality, and training intensities used for
the control group (standard training) were different. There was also a marked heterogeneity in the
sample of the included studies: elite (Javaloyes_2019 and Schmitt_2017) and amateur (Kiviniemi_2007,
Kiviniemi_2010, Nuuttila_2017, and Vesterinen_2016) participants, or samples comprising only men
(Javaloyes_2019, Kiviniemi_2007, Kiviniemi_2010, and Nuuttila_2017), women (Kiviniemi_2010), or
men and women (Schmitt_2017 and Vesterinen_2016). A standardized training protocol should be
recommended to ensure the optimal benefits regarding VO2max.
5.3. Quality of the Evidence
The quality of the evidence from the included studies can be considered unclear. Despite each
study being a randomized controlled trial, the sequence generation or the allocation concealment was
considered skewed in half of them. The performance bias was high only in Javaloyes_20019, while the
detection bias was unclear in all the studies because incomplete blinding was considered. Attrition
was high in Kiviniemi_2010, Nuuttila_2017, and Vesterinen_2016 because of the high follow-up rates.
In addition, the reporting bias was generally unclear due to the lack of a registered protocol.
5.4. Potential Biases in the Review Process
Although the systematic nature of the review process followed here decreases the potential for
bias, the risk of bias in the review process remains. The greatest risk of bias present in this review was
the study selection; specifically, the decision to limit the inclusion criteria to individual endurance
sports, thus reducing the number of studies included and causing a potential limitation in the results.
• Agreements and disagreements with other studies or reviews
Based on the results from this systematic review with meta-analysis, and in response to Research
Question 1, it is not surprising that the meta-analyzed results regarding improvements in athletes’
VO2max were associated with both training methodologies. According to Bartlett, O’Connor, Pitchford,
Torres-Ronda, and Robertson [2] and Heyward [37], adequate prescribed training should maximize
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athletic performance when the specificity, overload, progression, initial level, individualization,
diminishing return, and reversibility principles are followed. However, it was also found that the
individual training adaptation according to the endurance athletes’ daily HRV scores produced
better VO2max results than the standardized prescribed training, which answers Research Question 2.
As pointed out by Vesterinen et al. [4,9], not every athlete improves their VO2max after standardized
group training. Similarly, Gallo, Cormack, Gabbett, Williams, and Lorenzen [38] reported that,
in footballers, the internal load (perceived effort) of each athlete was different for a given external
load; this definitely affects their individual performance during training and will be reflected in
their individual performance improvements. Thus, daily individual HRV monitoring and training
guidance balancing the sympathetic and parasympathetic autonomic nervous system leads to greater
athletic performance in endurance athletes compared to standardized prescribed training. This is
relevant if training optimization is the objective, supporting the idea that training should be prescribed
appropriately to avoid overtraining and/or injury [38]. In the same vein, it is also interesting to point
out that, according to studies such as Hulin, Gabbett, Lawson, Caputi, and Sampson [39] and Williams
et al. [16], training individualization is also related to minimizing overuse and reducing the injury risk,
which may be a correlative benefit in the pursuit of endurance athlete training optimization.
On the other hand, the meta-analyzed results show that VO2max improvements were greater when
the sample comprised amateur endurance athletes. This answers Research Question 3. According to
the initial training level principle [37], individuals with a low initial level of physical fitness should
achieve more significant relative increases than those of average or high levels. This is in accordance
with the results of Sanchez-Sanchez et al. [40], where greater performance improvements were obtained
in lower-level football players compared to the higher-level players, concluding that the lower the
athlete’s initial fitness level, the higher the available window of adaptability. Conversely, in the
systematic review with meta-analysis by Hammami, Gabbett, Slimani, and Bouhlel [41], the athlete’s
level was not a determinant variable in terms of VO2max enhancement since it improved if they were
elite or amateur players. It should be noted that this review was conducted on football players and
that randomized and nonrandomized controlled trials were included.
According to our meta-analyzed results, and in response to Research Question 4, there were
higher effect sizes regarding VO 2max improvements when the sample was not mixed, especially in the
case of women. There is controversy concerning the influence of sex on sport performance. Recent
studies conducted on endurance athletes concluded that either sex was not a predictor variable of
performance [42] or that performance between men and women was different in swimming, cycling,
and running [43]. In the case of the present systematic review with meta-analyses, we consider
that the initial level of the sample influenced the result, given that, in the Kiviniemi_2010 study,
when female samples were analyzed, the participants were amateur level athletes. Thus, a higher
relative performance increment is predictable based on the athletes’ level.
6. Conclusions
6.1. Practical Implications
Training optimization to enhance performance in endurance athletes is a goal that is undergoing a
constant process of improvement. Finding a procedure to objectively individualize the training would
be ideal for achieving this goal. The meta-analyses results considered in this review suggest that HRV
is a good indicator of physiological responses to training in endurance athletes. Consequently, using
daily HRV scores for training individualization and prescription is an effective method for optimizing
performance in endurance athletes. This is reflected in the improved VO2max results when the training
is guided by HRV, considering VO2max as one of the main performance indicators. In addition, it should
be taken into account that a lower initial athlete fitness level will be relevant in achieving greater
VO2max improvement. Although gender may be a variable that influences the performance gains,
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in our opinion, this result is primarily conditioned by the level of the athletes included in the analyzed
studies. Therefore, we do not consider it to be a variable that clearly affects VO2max improvements.
6.2. Research Implications
The results from this review suggest that, while there is evidence that HRV-guided training is
effective at improving VO2max in endurance athletes, there is still work to be done in terms of identifying
the characteristics of the interventions that contribute to this effect and the characteristics of participants
who are more likely to respond to such interventions. The most important point is that more research
is required since only five studies were included in this review. Moreover, only two of the studies
used samples composed of elite endurance athletes, which gave different results regarding VO2max
improvement. Consequently, the research should be extended to the professional field in order to
clarify the effect of guiding training on VO2max. This would also help to clarify whether the endurance
sport modality is determinative of the VO2max enhancement when following this training methodology.
Using daily HRV scores to control the training load and intensity over eight weeks is enough
to improve VO2max in endurance athletes. Nonetheless, the training protocol should be further
standardized in terms of adjusting the number of preparation weeks or considering the measurement
weeks within or around the training period, factors that determine the training duration. Moreover,
the standardized training protocol used in the control groups varied between the studies, which
considered low, moderate, or high training intensities, as well as different numbers of sessions per
week and session durations. This might very well have influenced the VO2max results. Therefore,
it is necessary to reach a consensus regarding a standardized training protocol to use in future
studies. In this line, it has been recently published a protocol [44] that could clarify the studies design.
Similarly, although each study in this review used the most accurate method available to obtain the
cardiorespiratory data, in the future, we should consider using a measuring instrument that allows us
to implement the most specific sport technique in order to minimize result variability and imprecision.
Regarding the quality of the studies, authors should consider: improving the sequence generation
or allocation concealment, the blinding of the participants, personnel, and outcome assessors, the rates
of follow-up loss, using statistical procedures such as intention-to-treat to minimize attrition bias,
and registering their protocols before starting the randomized controlled trial.
Lastly, to reinforce knowledge regarding performance optimization in endurance athletes, a good
way to supplement the effect of HRV-guided training might be to register the risk of injuries associated
with overuse using tools such as the Oslo Sports Trauma Research Center Overuse Injury Questionnaire,
since this considers additional aspects affecting the execution of athletes’ training.
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